CRL vs RCAT · rev $2.00B vs rev $35.7M
Charles River Laboratories (CRL) versus Red Cat Holdings Inc (RCAT) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Red Cat Holdings Inc (RCAT) is a aerospace & defense company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported RCAT revenue for 2026-06-30 was $35.7M. Net income was -$61.8M. RCAT currently screens at market cap $1.70B.
CRL currently screens at market cap $7.78B. RCAT currently screens at market cap $1.70B.
Not investment advice. Open the CRL and RCAT stock pages for the full models.
Not investment advice.